Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Clinical trial NCT06580314 · RECRUITING

Trial details

NCT number: NCT06580314
Sponsor: NRG Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube High Grade Serous Adenocarcinoma Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor FIGO Stage III Ovarian Cancer 2014 FIGO Stage IV Ovarian Cancer 2014 Ovarian Carcinoma Ovarian Carcinosarcoma Ovarian High Grade Endometrioid Adenocarcinoma Ovarian High Grade Serous Adenocarcinoma Primary Peritoneal Carcinosarcoma Primary Peritoneal Endometrioid Adenocarcinoma Primary Peritoneal High Grade Serous Adenocarcinoma

Start date: 2025-03-12
Primary completion: 2034-12-31
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.